N. Shand

2.1k total citations
25 papers, 1.6k citations indexed

About

N. Shand is a scholar working on Molecular Biology, Agronomy and Crop Science and Genetics. According to data from OpenAlex, N. Shand has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Agronomy and Crop Science and 6 papers in Genetics. Recurrent topics in N. Shand's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Reproductive Physiology in Livestock (7 papers) and Veterinary Equine Medical Research (6 papers). N. Shand is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Reproductive Physiology in Livestock (7 papers) and Veterinary Equine Medical Research (6 papers). N. Shand collaborates with scholars based in Switzerland, United States and New Zealand. N. Shand's co-authors include Katharine Hazell, Ian Judson, Heidi A. Lane, Suzanne F. Jones, Howard A. Burris, Éric Raymond, John M. Kovarik, Susan Alexander, Anne O’Donnell and Daniel Rea and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Clinical Nutrition and British Journal of Cancer.

In The Last Decade

N. Shand

25 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Shand Switzerland	16	1.0k	545	489	267	204	25	1.6k
Celina M. D’Cruz United States	16	1.1k 1.1×	688 1.3×	493 1.0×	265 1.0×	299 1.5×	38	1.8k
Gudrun Meinhardt Austria	25	1.4k 1.3×	335 0.6×	192 0.4×	91 0.3×	231 1.1×	63	2.3k
Kensuke Kojima Japan	29	1.8k 1.8×	1.1k 2.0×	155 0.3×	81 0.3×	283 1.4×	135	2.9k
Masafumi Koshiyama Japan	24	699 0.7×	602 1.1×	200 0.4×	143 0.5×	266 1.3×	81	2.0k
Zhong Wu China	23	922 0.9×	328 0.6×	370 0.8×	146 0.5×	439 2.2×	86	1.7k
L. M. Ellis United States	12	585 0.6×	371 0.7×	225 0.5×	83 0.3×	244 1.2×	20	1.1k
Laith Dabbagh Canada	15	549 0.5×	546 1.0×	194 0.4×	60 0.2×	160 0.8×	23	1.3k
Kevin J. Wu United States	19	1.1k 1.1×	218 0.4×	456 0.9×	117 0.4×	435 2.1×	51	1.8k
Janice G. Dodd Canada	20	733 0.7×	271 0.5×	664 1.4×	294 1.1×	197 1.0×	33	1.6k
William B. Isaacs United States	24	1.1k 1.1×	283 0.5×	797 1.6×	447 1.7×	415 2.0×	41	2.0k

Countries citing papers authored by N. Shand

Since Specialization

Citations

This map shows the geographic impact of N. Shand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Shand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Shand more than expected).

Fields of papers citing papers by N. Shand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Shand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Shand. The network helps show where N. Shand may publish in the future.

Co-authorship network of co-authors of N. Shand

This figure shows the co-authorship network connecting the top 25 collaborators of N. Shand. A scholar is included among the top collaborators of N. Shand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Shand. N. Shand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sneddon, Elizabeth A., et al.. (2025). Early life stress paired with adolescent alcohol consumption reduces two‐bottle choice alcohol consumption in mice. Alcohol Clinical and Experimental Research. 49(3). 678–691. 1 indexed citations

Campone, M., Vincent Lévy, Emmanuelle Bourbouloux, et al.. (2009). Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours. British Journal of Cancer. 100(2). 315–321. 74 indexed citations

Tanaka, Chiaki, Terence O’Reilly, John M. Kovarik, et al.. (2008). Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic Data. Journal of Clinical Oncology. 26(10). 1596–1602. 168 indexed citations

O’Donnell, Anne, Sandrine Faivre, Howard A. Burris, et al.. (2008). Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 26(10). 1588–1595. 371 indexed citations

Tabernero, Josep, Federico Rojo, Emiliano Calvo, et al.. (2008). Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 26(10). 1603–1610. 423 indexed citations

Burris, H.A., Suzanne F. Jones, Sara B. Calvert, et al.. (2006). Summary of results in patients with metastatic renal cell cancer (RCC) from phase I studies of RAD001 (everolimus). Journal of Clinical Oncology. 24(18_suppl). 14599–14599. 9 indexed citations

Oosterom, A. van, Peter Reichardt, Jean‐Yves Blay, et al.. (2005). A phase I/II trial of the oral mTOR-inhibitor everolimus (E) and imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM: Study update. Journal of Clinical Oncology. 23(16_suppl). 9033–9033. 37 indexed citations

Tabernero, Josep, Federico Rojo, H.A. Burris, et al.. (2005). A phase I study with tumor molecular pharmacodynamic (MPD) evaluation of dose and schedule of the oral mTOR-inhibitor Everolimus (RAD001) in patients (pts) with advanced solid tumors. Journal of Clinical Oncology. 23(16_suppl). 3007–3007. 53 indexed citations

Lerut, Evelyne, Tania Roskams, Douglas Bootle, et al.. (2005). Molecular pharmacodynamic (MPD) evaluation of dose and schedule of RAD001 (everolimus) in patients with operable prostate carcinoma (PC). Journal of Clinical Oncology. 23(16_suppl). 3071–3071. 17 indexed citations

10.

Pacey, Simon, Daniel Rea, Neil Steven, et al.. (2004). Results of a phase 1 clinical trial investigating a combination of the oral mTOR-inhibitor Everolimus (E, RAD001) and Gemcitabine (GEM) in patients (pts) with advanced cancers. Journal of Clinical Oncology. 22(14_suppl). 3120–3120. 10 indexed citations

11.

Dumez, Herlinde, Jayesh Desai, Sigrid Stroobants, et al.. (2004). Combination signal transduction inhibition: a phase I/II trial of the oral mTOR-inhibitor everolimus (E, RAD001) and imatinib mesylate (IM) in patients (pts) with gastrointestinal stromal tumor (GIST) refractory to IM. Journal of Clinical Oncology. 22(14_suppl). 3002–3002. 44 indexed citations

12.

Alexander, Susan, et al.. (2000). The role of endogenous opioids in the ovulatory LH surge in mares.. PubMed. 217–26. 3 indexed citations

13.

Shand, N., Friedrich Weber, Luigi Mariani, et al.. (1999). A Phase 1-2 Clinical Trial of Gene Therapy for Recurrent Glioblastoma Multiforme by Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene Followed by Ganciclovir. Human Gene Therapy. 10(14). 2325–2335. 192 indexed citations

14.

Long, Zhifeng, et al.. (1999). Molecular Evaluation of Biopsy and Autopsy Specimens from Patients Receiving in Vivo Retroviral Gene Therapy. Human Gene Therapy. 10(5). 733–740. 29 indexed citations

15.

Shand, N., et al.. (1998). Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas. American Journal of Clinical Nutrition. 68(6). 1462S–1465S. 64 indexed citations

16.

Irvine, C. H. G., et al.. (1998). Gonadotrophin profiles and dioestrous pulsatile release patterns in mares as determined by collection of jugular blood at 4 h intervals throughout an oestrous cycle. Reproduction. 113(2). 315–322. 19 indexed citations

17.

Shand, N., Susan Alexander, & C. H. G. Irvine. (1995). Oxytocin Secretion Patterns in Normal Stallions as Measured in Pituitary Venous Blood: Correlation with Gonadotropin Secretion and Effect of Sexual Arousal1. Biology of Reproduction. 52(monograph_series1). 565–575. 4 indexed citations

18.

Alexander, Susan, C. H. G. Irvine, N. Shand, & M. J. Evans. (1995). Is Luteinizing Hormone Secretion Modulated by Endogenous Oxytocin in the Mare? Studies on the Role of Oxytocin and Factors Affecting Its Secretion in Estrous Mares1. Biology of Reproduction. 52(monograph_series1). 361–371. 15 indexed citations

19.

Shand, N., et al.. (1991). Comparison of the microheterogeneity of horse LH and FSH in the pituitary with that secreted into pituitary venous blood at oestrus.. PubMed. 44. 1–11. 13 indexed citations

20.

Shand, N., et al.. (1988). Sandimmun^R(Cyclosporin A): Mode of Action and Clinical Results in Rheumatoid Arthirtis. Scandinavian Journal of Rheumatology. 17(sup76). 265–278. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact